Skip to Content

Corteva Inc CTVA

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Corteva's First-Quarter Results Show Profit Growth From Premium Products; Shares Fairly Valued

Seth Goldstein, CFA Senior Equity Analyst

Analyst Note

| Seth Goldstein, CFA |

Corteva reported solid first-quarter earnings, as operating EBITDA was up 14% versus the prior-year quarter. The growth was driven by higher prices and volumes as well as a greater proportion of premium products in both seeds and crop protection. Management raised its revenue guidance to account for higher crop protection sales but left full-year operating EBITDA and operating EPS guidance unchanged, as higher input costs would offset the improved sales. Given the favorable ag backdrop with higher crop prices, we think Corteva should benefit from higher volumes in both seeds and crop protection as farmers plant more crops this year. As such, we have increased our forecast and now expect profits to come in at the high end of management's guidance range. After updating our model to incorporate the first-quarter results, we raise our Corteva fair value estimate to $45 per share from $44. Our wide moat rating is unchanged.

Read Full Analysis

Company Profile

Business Description

Corteva was formed in 2019 as the agriculture division of the DowDuPont merger and subsequent separation. The company is a leader in the development of new seed and crop chemicals products. Seeds generate a little over half of total company profits and crop protection chemicals make up the remainder. Although Corteva operates globally, around half of revenue comes from North America.

Contact
974 Centre Road
Wilmington, DE, 19805
T +1 302 774-1000
Sector Basic Materials
Industry Agricultural Inputs
Most Recent Earnings Dec 31, 2020
Fiscal Year End Dec 31, 2019
Stock Type Cyclical
Employees 21,000

Related